Alaunos Therapeutics (TCRT) Non-Current Deffered Revenue (2011 - 2018)
Alaunos Therapeutics' Non-Current Deffered Revenue was $49.51 million in Q2 2018, up 29.2% from $38.33 million a year earlier and up 1.0% from the prior quarter.
Alaunos Therapeutics (TCRT) Non-Current Deffered Revenue (2011 - 2018) Analysis & Trends
At the end of FY2017, Non-Current Deffered Revenue at Alaunos Therapeutics came in at $35.14 million, down 15.4% from FY2016.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 66.7% (FY2012 to FY2017).
- In earlier years, Non-Current Deffered Revenue was $41.53 million in FY2016 (-13.3%), $47.92 million in FY2015 and $1.93 million in FY2013 (-29.3%).
- The Q2 2018 figure marks the highest quarterly Non-Current Deffered Revenue since Q3 2015.
- Compared with a year earlier, Non-Current Deffered Revenue was higher in two of the last eight quarters, with an average decline of 4.1%.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q2 2018 (growth of 29.2%); the worst was Q1 2014 (a decline of 31.6%).
- Per Business Quant data, TCRT's Non-Current Deffered Revenue in the three quarters before Q2 2018 was $49.04 million (Q1 2018), $35.14 million (Q4 2017) and $36.74 million (Q3 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Alaunos Therapeutics | 2.24 Mn | -1.56 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 49.51 Mn |
| Mar 31, 2018 | 49.04 Mn |
| Dec 31, 2017 | 35.14 Mn |
| Sep 30, 2017 | 36.74 Mn |
| Jun 30, 2017 | 38.33 Mn |
| Mar 31, 2017 | 39.93 Mn |
| Dec 31, 2016 | 41.53 Mn |
| Sep 30, 2016 | 43.13 Mn |
| Jun 30, 2016 | 44.72 Mn |
| Mar 31, 2016 | 46.32 Mn |
| Dec 31, 2015 | 47.92 Mn |
| Sep 30, 2015 | 49.51 Mn |
| Mar 31, 2014 | 1.73 Mn |
| Dec 31, 2013 | 1.93 Mn |
| Sep 30, 2013 | 2.13 Mn |
| Jun 30, 2013 | 2.33 Mn |
| Mar 31, 2013 | 2.53 Mn |
| Dec 31, 2012 | 2.73 Mn |
| Sep 30, 2012 | 2.93 Mn |
| Jun 30, 2012 | 3.13 Mn |
Alaunos Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TCRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TCRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();